|
|
|
Praveen Advani
Director/Team Leader, Global Market Research & Analytics
Merck & Co., Inc.
Praveen Advani has more than 14 years of experience leading global market research efforts for new products and in-line brands in the
Pharmaceutical Industry. Praveen currently is the Director & Team Leader for Womens Health, Insomnia and Pain Franchises in Global Market
Research & Analytics at Merck. He has also successfully led global market research efforts for the launches of Diabetes (Januvia and
Janumet) and Glaucoma (Saflutan) drugs at Merck in the last 7 years.
Prior to Merck, Praveen was with Aventis Pharmaceuticals (now Sanofi-Aventis) for 6 years and was instrumental in leading global market
research for the successful launch of Lantus. Praveen holds a Bachelors degree in Engineering from the University of Pune, India and a M.B.A.
from Thunderbird, The American Graduate School of International Management.
_________________________________________________________________________________________________
|
|
|
|
Dr. Muneer Ahmad
Associate Director, Consulting Practice
Lifescience Dynamics
Muneer Ahmad is an Associate Director in Lifescience Dynamics’ consulting practice, and is based in the firm’s UK office. Muneer holds a Ph.
D. in Biochemistry with research experience in molecular biology and recombinant DNA technology. He’s been working in the pharma industry
for over 10 years on international market research projects and has been extensively involved in delivering projects in the emerging markets
including Asia.
_____________________________________________________________________________________________________________
|
| |
|
Candace Anderson
Senior Manager, Primary Market Research
Auxilium Pharmaceuticals
_______________________________________________________________________________________________________________
|
|
|
|
Joann Androconis
Former Director, Market Research Excellence
Merck & Co., Inc.
Joann is a seasoned professional from Merck with 15 years of Market Research experience. Joann has broad pharmaceutical experience
across many therapeutic areas, customers and Global markets. Joann has held a number of different roles each with increasing responsibility
in finance, forecasting, competitive intelligence, market research and learning & development.
_______________________________________________________________________________________________________________
|
| |
|
Zack Apkarian
Sr. Director, Global Analytics
Pfizer Consumer Healthcare
_______________________________________________________________________________________________________________
|
|
|
|
Tamara Barber
Senior Director Strategic Marketing
Affinnova
Tamara Barber is currently Sr Director of Strategic Marketing at Affinnova, the global leader in marketing innovation software and services. Prior
to joining Affinnova, she was a Senior Analyst at Forrester Research, where she advised market insights professionals on the changing
landscape of research methodologies and technologies.
She is also a leading expert in Hispanic consumer behavior and technology adoption. She launched Forrester's Hispanic research product in
2005 and received the 2010 ad:tech industry achievementaward for her work in the multicultural marketing space. Before this, she was a
consultant at CANIETI (Mexico's chamber of commerce for the telecom, electronics, and IT industry), where she conducted primary research
and analysis on the industry's competitiveness and innovative capacity. She began her technology and marketing career as a corporate PR
manager at Apple.
Tamara holds a Master's degree in international business and development economicsfrom the Fletcher School at Tufts University.
_______________________________________________________________________________________________________________
|
|
|
|
Jordan Bayless
Executive Director
Optimal Strategix Group
Jordan Bayless works closely with various client teams and offers valuable understanding of the market place to help his clients make better
informed decisions. He fully dedicates himself to a thorough understanding of unmet needs and presents detailed strategies for profitable
growth.
Jordan’s areas of focus include marketing research, marketing strategy, customer experience, and segmentation. He is responsible for
leading a client delivery team that serves several of OSG’s top accounts.
During his career, Jordan has delivered many projects for clients in the Business to Business, Consumer Durables, Entertainment, Consumer
Packaged Goods, and Healthcare industries. His experience in healthcare includes working in such categories as insomnia, pain, virology,
neurology, metabolic syndrome, mental health, vaccines, respiratory, surgical products, medical devices, and oncology.
Prior to joining Optimal Strategix Group, he held various US based and foreign based positions in large international corporations as well as
small businesses. Just before moving from the client side to becoming a consultant, he was responsible for creating and leading a team
focused on customer experience improvement for a large international airline.
Jordan has presented at and received awards from conferences such as EphMra and CBI, and holds an M.B.A. from Thunderbird, The
American Graduate School of International Management, and a Bachelors Degree in Commercial German and Business Administration from
Weber State University.
_________________________________________________________________________________________________
|
|
|
|
Betsy Benning
Strategic Market Intelligence Lead, ExenatideOne
Amylin Pharmaceuticals
Betsy Benning currently leads the team at Amylin Pharmaceuticals responsible for primary market research, forecasting and marketing
analytics. Prior to joining Amylin in 2003, Betsy worked on the supplier side for G & S Research where she gained a deep appreciation for the
importance of building strong relationships with external partners.
She has extensive marketing and market research experience working for a range of firms from the very large, Eli Lilly & Company, to small
start-ups in San Diego. In addition to her expertise in diabetes, she has worked on products in therapeutic areas such as oncology, HIV/AIDS,
and human growth hormone.
Betsy holds a BA in Economics from Agnes Scott College and an MBA from the Amos Tuck School of Business at Dartmouth College.
_______________________________________________________________________________________________________________
|
| |
|
Dr. Barry M. Berger
Senior Vice President, Medical Affairs, Chief Medical Officer
Exact Sciences Corporation
Barry Berger has more than 30 years of experience in healthcare. He is currently works in the molecular diagnostics industry managing
medical affairs. He has also directed a Department of Pathology and Laboratory Medicine for a multi-specialty staff model HMO. He is an
experienced clinician in primary care, emergency room, and laboratory setting. He is on the American Board of Pathology certified in
Anatomic/Clinical Pathology and Cytopathology.
_________________________________________________________________________________________________
|
|
|
|
Daryl M. Bogard, RPh, MBA
Sr. Director, Global Marketing Research
Allergan, Inc.
Daryl was raised in Illinois, educated in Iowa and worked on three coasts. He is a third-generation pharmacist who has spent his entire
professional career in the pharmaceutical industry, one-fifth of it in sales and the balance in marketing research. Daryl started his career with
Parke-Davis working as a sales rep in Houston, TX, and progressed into International Marketing Intelligence with the parent company,
Warner-Lambert in Morris Plains, NJ. He is approaching his 20th year with Allergan, Inc. in Irvine, CA, where he leads the Global Marketing
Research department.
Daryl is married with four children. He has traveled extensively, visiting all 50 US states and 109 countries. He is an avid sports participant
and spectator.
_________________________________________________________________________________________________
|
|
|
|
Scott Brunetto
Director, Global Market Research
Shire Pharmaceuticals
Scott has managed all levels of pharmaceutical research and analytics including primary market research, secondary data analysis,
forecasting, competitive intelligence and sales force analytics. He has worked on both the client and supplier side, providing insights across
customer segments for in-line and new product research.
Scott joined Shire after several years at Johnson & Johnson, and IMS America. He is a graduate of the George Washington University.
_______________________________________________________________________________________________________________
|
| |
|
Carin Burke
Director, Marketing Analytics & Sciences
Noven
Carin Burke has worked in the pharmaceutical industry for over 30 years in a broad range of disciplines. Her current role is at Noven
Pharmaceuticals where she provides leadership and marketing analytics expertise to in-line brands, new products and business
development. Prior to joining Noven, Carin was Director, Business Analytics at Johnson & Johnson, overseeing market research, forecasting,
and competitive intelligence for key therapeutic areas. She also has extensive sales and finance experience.
_______________________________________________________________________________________________________________
|
| |
|
Millie Cason
Director of Intelligence
Astellas Pharma
Millie Cason is the Director of Competitive Intelligence for Astellas Pharma US. Ms. Cason has over 15 years of experience in competitive
intelligence, strategy and decision support for companies including Astellas, Amgen and Abbott.
In current and previous roles, Ms. Cason has spearheaded the establishment of the competitive intelligence function. She has extensive
experience and success in developing and implementing early warning systems, business war games and global monitoring programs that
support brand management, marketing, regulatory and R&D functions.
_______________________________________________________________________________________________________________
|
| |
|
Paul Ciavolella
Director, Business Analytics
Pacira Pharmaceuticals, Inc.
Paul Ciavolella currently serves as the Director of Business Analytics with Pacira Pharmaceuticals and is responsible for sales operations and
market research.
Paul holds a BS in Biology from SUNY Stony Brook and prior to joining Pacira Pharmaceuticals, Paul has held has various leadership roles in
field sales, incentive compensation, decision analytics, sales force effectiveness, product management and market research.
_______________________________________________________________________________________________________________
|
| |
|
Karissa Cliff
Associate Director of Global Customer Insights
Mead Johnson
_______________________________________________________________________________________________________________
|
| |
|
Gerarda Collins
Former Director/Team Leader, Global Market Research & Analytics
Merck & Co., Inc.
_______________________________________________________________________________________________________________
|
|
|
|
Lisa Courtade
Senior Director, Global Market Research & Analytics
Merck & Co., Inc.
Lisa is currently Senior Director, Global Market Research & Analytics at Merck & Co where she leads the Primary Care and Women's Health
research team in providing strategic customer insights to drive brand, franchise, and customer strategy in this important business sector.
A seasoned professional with over 20 years of marketing research experience, Lisa has led both research teams for a number of multi-
national pharmaceutical companies. Lisa joined Merck in 2004 to lead the Global Neuroscience Team and has held roles of increasing
responsibility supporting the development and commercialization of products across a range of therapeutic areas including respiratory
disease, osteoporosis, women's health, diabetes and obesity, cardiovascular disease, neuroscience, ophthalmics, derm, and oncology.
Prior to joining Merck, Lisa was employed by Aventis Pharmaceuticals (now Sanofi Aventis) where she was the Director of Global Market
Analytics for metabolism. In this role, Lisa provided global leadership for the metabolism team, directing the planning, design, and execution of
research and forecasting to support launched products across key global markets as well as inform development of investigational
compounds and in-licensing opportunities for entry into the diabetes marketplace.
Lisa rejoined the Aventis family following the acquisition of Pharmacia by Pfizer. During her time with Pharmacia, Lisa headed the Celebrex™
Global and US marketing research teams, coordinating research initiatives across the portfolio and global markets within the Pfizer/Pharmacia
Cox-2 Alliance.
Prior to joining Pharmacia, Lisa led the secondary and primary marketing research team for Connaught Labs, now Sanofi-Pasteur, the vaccine
division of Sanofi Aventis.
Although Lisa has spent the majority of her research career in the pharmaceutical industry, her research career has included responsibility for
US and Global primary and secondary research as well as forecasting across several business sectors including healthcare, electronics,
chemicals and municipal government.
Lisa has been an active member and volunteer of the Healthcare Businesswoman’s Association (HBA) for nearly two decades, serving on
various local committees as well as on the National Board as Director of Career Development and as the first Research Director for the Global
HBA Board. In this role, Lisa led the HBA’s research programs on leadership and industry issues. For the first of these programs, the H.A.I.L.
study (“HBA Attributes & Influences of Leaders”), was published in the August 2003 edition of Pharmaceutical Executive. Lisa also co-chaired
the HBA E.D.G.E. (Empowerment, Diversity, Growth, Excellence) in Leadership Study with fellow HBA member and 2008 Star Volunteer, Anne
Camille Talley. The EDGE study was a ground-breaking partnership between the HBA, industry, and Booz & Company, to establish
benchmarks, document corporate approaches and recommend best practices for women’s recruitment and advancement in pharma / biotech
companies internationally. This study demonstrated the HBA’s commitment to advancing women’s careers in the healthcare industry through
a research-based understanding of key issues.
Lisa holds a B.A., summa cum laude, in Business Administration and Marketing from Radford University in Virginia and a Masters in Marketing
Research from the University of Georgia.
_______________________________________________________________________________________________________________
|
|
|
|
Rich Daly
Former Executive Vice President, COO
Takeda Pharmaceuticals
Rich Daly has served at every level of the pharmaceutical industry – from sales representative to C-suite executive. Rich also parlayed his
training in microbiology into more than 20 years of industry commercial experience. He has played key roles in the launch of five
pharmaceutical companies, both in the US and globally. He has also helped lead six successful product launches including the world’s
largest selling diabetes brand, Actos. Additionally, he has led mergers, turn- arounds and global expansion initiatives.
Rich earned a BS in microbiology from the University of Notre Dame and an MBA from the Kellogg Graduate School of Management,
Northwestern University.
_______________________________________________________________________________________________________________
|
|
|
|
Dev Das
Group Director, Strategic Insights & Analytics
Auxilium Pharmaceuticals
Dev Das is Group Director of the Strategic Insights & Analytics group at Auxilium. His past includes nearly 20 years of new product marketing
and market research experience within the biopharmaceutical and consumer packaged goods industries. He began his career working with
consumer marketing leaders Procter & Gamble and Kraft Foods. He then worked on several new drug initiatives and joint ventures within
Bristol Myers Squibb. He now leads the market research efforts at Auxilium, an emerging biotech player.
Dev holds an MBA in Marketing/Operations Research from Case Western Reserve University and a B.Tech. from the Indian Institute of
Technology, Mumbai.
_________________________________________________________________________________________________
|
| |
|
Robert De Allaume
Global Strategic Analytics Director
Johnson & Johnson
Robert De Allaume is Global Strategic Analytics Director at Johnson and Johnson. He supports the cardiovascular and metabolics portfolio,
leading forecasting and market research. Rob has been with J&J for four years.
Prior to joining J&J, Rob was with Pfizer, including Animal Health Pharmaceuticals and the Consumer Group. Rob’s time in the Consumer
Group included positions in market research and new product marketing.
Rob lives in Morris County, NJ with his wife and son. He enjoys skiing, biking, cooking and travel.
_______________________________________________________________________________________________________________
|
|
|
|
Chris DeAngelis
Vice President of Strategic Initiative
SSI
Chris DeAngelis is Vice President of Strategic Initiatives at Survey Sampling International. Chris' focus is Healthcare. Chris has more than 20
years of experience in designing sampling solutions for a wide variety of research projects. Chris earned his MBA from the University of
Bridgeport, CT and his BA in Economics from Bates College. He is a member of PMRG, MRA, AMA and AAPOR.
_________________________________________________________________________________________________
|
|
|
|
Michael Devinoff
Executive Director, Forecasting, Epidemiology, and Predictive Analytics
Bristol-Myers Squibb
Michael Devinoff is an Executive Director at Bristol-Myers Squibb Co. He created and leads the Forecasting Team, a company-wide team
focusing on Strategic Forecasting, Launch Forecasting, Epidemiology, and Predictive Analytics. This group resides within the company’s
broader Worldwide Market Research and Business Intelligence organization.
Michael has been with Bristol-Myers Squibb Co. for over 10 years. During his tenure at BMS, Michael has perfected his Marketing Research
skills through ever-expanding roles within both the core US Pharmaceuticals and Global Marketing/Commercialization organizations. He has
led teams of Marketing Research analysts across various products and therapeutic categories. His extensive efforts within the Cardiovascular
group has helped grow the company’s most significant product, Plavix, into the world’s 2nd largest pharmaceutical brand.
Prior to his time with BMS, Michael spent four years with NFO-Migliara/Kaplan Associates, an industry-leading Marketing Research consulting
company. There he successfully built a multi-million dollar base of client business and led a broad team of research analysts addressing
strategic business questions across products spanning a variety of therapeutic categories and life-cycle stages.
Prior to his nearly 15 year tenure within the marketing research industry, Michael honed his analytical and business skill set through
experiences working at Becton Dickenson & Co. (marketing/marketing research), Baskin-Robbins (store management), Curtis 1000 (sales),
and Red Robin Restaurants (store management & training).
Michael holds an MBA in Marketing from Rutgers University Graduate School of Management, and a BS in Biology/Genetic Engineering from
Binghamton University.
Michael and his family live in the Princeton, NJ area.
_______________________________________________________________________________________________________________
|
|
|
|
Sandipa Dublish
Sr. Director Global MR
Alexion Pharmaceuticals
Sandipa Dublish is Sr. Director Global MR at Alexion Pharmaceuticals. In this role she manages all aspects of strategic business insights
including Competitive Intelligence. In her previous position as Director, Oncology Market Research with Bristol-Myers Squibb – Sandipa was
an active user of Competitive Intelligence. She therefore has a unique perspective on CI both as a provider and a user.
Sandipa holds a PhD. in Marketing from Florida International University and an MBA from Faculty of Management Studies, Delhi, India.
_______________________________________________________________________________________________________________
|
|
|
|
Tim Edbrooke
President
Healogix
Tim’s pharmaceutical career spans over 20 years and an impressive array of disciplines from clinical development through to the
commercialization of products and general management. At Healogix he is responsible for all aspects of our day to day operations and most
importantly ensuring that we create highly effective partnerships with our clients that help drive their businesses forward.
Tim’s experience of working on both the client and services side of the industry affords him an excellent understanding of what clients require
and an appreciation of how to make it happen.
Tim was most recently the Chief Executive Officer at Genactis, Inc., a market research consultancy specializing in the Pharmaceutical and
Biotechnology industry. Prior to that he held executive leadership roles at TVG Inc. as well as GfK Healthcare (formerly NOP World Health) with
responsibility for business development and marketing activities. Tim started his career in the UK on the client side at Merck Sharpe & Dohme
and later moved to Organon Teknika where he assumed full P&L responsibilities for the Pharmaceutical Division.
_______________________________________________________________________________________________________________
|
|
|
|
Mark Edelstein
Former Senior Director Market Research
Lundbeck Inc.
As an accomplished marketing research and competitive intelligence professional, Mark has been successful both as a consultant and in
corporate marketing research roles, providing insight and perspective to guide many successful pharmaceutical products through pre-clinical,
launch and mature life-cycle stages. He has helped drive commercialization and licensing decisions through his active assessments of BD
opportunities.
Mark most recently served as Senior Director Marketing Research and Competitive Intelligence with Lundbeck U.S (formerly Ovation
Pharmaceuticals). His extensive corporate career includes marketing research leadership positions with Searle/Pharmacia, Abbott
Laboratories, G.D. Searle, and Merck. Earlier career roles were in chemical engineering assignments with FMC Corporation and Procter &
Gamble.
Since 2001, Mark also has been President of MECI, the consulting firm he founded. MECI delivers strategic and tactical insights to the global
healthcare industry through marketing research initiatives and partnerships at client and consultant companies. Additional consulting
affiliations have included The Planning Shop, a UK research-based brand consultancy to the global pharmaceutical industry, where as Vice
President, Planning Shop NA, Mark was responsible for leading marketing research initiatives for U.S.-based global companies.
Mark is a graduate of Lehigh University, where he earned a BS Chemical Engineering degree. He later received his Masters Degree in
Marketing from Drexel University.
Numerous professional associations with which Mark is affiliated and actively involved include the Pharmaceutical Marketing Research Group
(PMRG), Pharmaceutical Business Intelligence Research Group (PBIRG), Pharma Market Research Conference, Pharma Competitive
Intelligence Conference, and the American Marketing Association, to name a few.
Mark and his wife, Lael and children currently reside in Buffalo Grove, IL.
_______________________________________________________________________________________________________________
|
| |
|
Derek Fetzer
Director, Market Research - Virology
Johnson & Johnson
_______________________________________________________________________________________________________________
|
| |
|
Nikhil Gadre
Assoc. Director, Global Access - Oncology
Bristol-Myers Squibb
_______________________________________________________________________________________________________________
|
|
|
|
Roger Green
President/CEO
Roger Green and Associates, Inc.
Mr. Green founded Roger Green and Associates, Inc. (RG+A) in 1991 and serves as President and Chief Executive Officer. Over the past
twenty years, Roger has worked to design marketing research methods, insights, and modeling tools that promote greater understanding of
what drives value in pharmaceutical markets. He is the primary developer of Dynamic Practice Simulation® (DPS®), RG+A’s proprietary patient-
simulating marketing research system, which has been applied successfully in virtually every major market around the world.
Mr. Green is a past President of the Pharmaceutical Marketing Research Group (PMRG). He has sat on editorial boards, has written articles
and participated in roundtables for leading industry publications, and lectured widely at prominent university programs involved with marketing
research and pharmaceutical marketing. He received a BA in political science and an MBA in marketing from Columbia University.
Mr. Green is the 2008 recipient of the R.R. Fordyce Award, an honor bestowed upon leaders in the marketing research industry dedicated to the
betterment of the profession.
_______________________________________________________________________________________________________________
|
|
|
|
Stuart Greenberg
Deputy Director, Global/Oncology Market Research
Bayer Healthcare
Dr. Stuart E. Greenberg is currently Deputy Director, Global / Oncology Market Research at Bayer. His responsibilities include qualitative and
quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global
Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on
cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned
his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
He currently resides in Central New Jersey with his wife Randi and children, Max and Dena.
_______________________________________________________________________________________________________________
|
|
|
|
Johanne Guarda
Business Development
Medefield
Johanne has more than 20 years' healthcare market research experience, including client, full-service and fieldwork agency roles. At
Medefield, she has responsibility for all client-facing activities in North America, including client development and client services. Johanne
spent the first 9 years of her career client-side at Hoechst Roussel in a variety of roles including sales and marketing, before working for 8
years consulting for full-service agency, P\S\L Research Canada. Whilst working as a research consultant, Johanne worked across a broad
mix of methodologies, including qualitative, quantiative and online research. She has spent the last 6.5 years specialising in online fieldwork
at Medefield.
_______________________________________________________________________________________________________________
|
| |
|
Dr. Ted Gutowski
Member of a Group Practice
Manalapan, NJ
Ted Gutowski is board certified in both internal medicine and Cardiovascular Diseases and has bee practicing since 1986. He has a
teaching appointment at Robert Wood Johnson Medical School, is an attending physician at two hospitals, and a case load of more than 300
patients per month.
_______________________________________________________________________________________________________________
|
|
|
|
Jennifer Guzman
Director, Marketing
Teva Health Systems
Jennifer Guzman has more than 17 years of medical industry commercial experience in biotech, pharmaceuticals and medical device. She
has extensive experience in specialty market organizations and in transitioning a company from start-up to commercialization. She has played
key roles in marketing and launching products in the following markets: oncology, HIV, pain, neuroscience, and cardiology. She has also led
marketing and sales operations teams for both brand and generic companies. Currently Jennifer is Director of Marketing for Teva Health
Systems, responsible for all strategic and tactical initiatives for Teva USA into the Health Systems segment.
Jennifer earned a BA in sociology from the University of California, San Diego and an MBA with an emphasis in marketing from San Diego
State University.
_______________________________________________________________________________________________________________
|
| |
|
Anne Hale
Senior Director/Team Leader
Pfizer Inc.
_______________________________________________________________________________________________________________
|
| |
|
Mike Halpin
Director, Market Research ADHD
Shire Pharmaceuticals
_______________________________________________________________________________________________________________
|
|
|
|
Michael Hay
Vice President/Product Manager
BioMedTracker
Michael Hay, Vice President/Product Manager, Sagient Research Systems. Michael has been with Sagient for over seven years and has over
11 years of financial markets experience. He manages the BioMedTracker analyst team and serves as Vice President at Sagient. He is also
responsible for product development, corporate planning and sales and marketing. Michael has consulted numerous top tier pharmaceutical
companies on strategic decisions as well as worked closely with top healthcare investment firms providing insight on investment and trading
decisions. Michael's financial markets career began at Thomson Financial in 2000. He reached the position of Manager, Capital Markets
Intelligence and was directly responsible for corporate client relationships within the Technology sector. At Thomson he consulted senior
management regarding shareholder composition, financial markets and competitive positioning. Michael received a Bachelor of Science
degree in Finance from University of Colorado, Boulder.
_______________________________________________________________________________________________________________
|
| |
|
John Hines
Director - Market Research HCP & Trade
Pfizer Nutrition
_______________________________________________________________________________________________________________
|
| |
|
Raj Joshi
Manager, Strategic Sourcing
Allergan, Inc.
_______________________________________________________________________________________________________________
|
| |
|
Kumar Kantheti
Director of Portfolio Management and Strategic Planning
Shionogi Inc
Kumar is currently Director of Portfolio Management and Strategic Planning at Shionogi, Inc., a Japanese pharmaceutical company, whose US
headquarters is based in Florham Park, New Jersey. In this role Kumar is engaged in the development and implementation of a
comprehensive Portfolio Management process in the Global Development Organization. In addition, he is responsible for providing strategic
planning support for development projects in order to maximize the commercial value of pipeline assets. Prior to taking this position, Kumar
headed up the Market Research function and the Sales Operations team, both within the Commercial organization of Shionogi, Inc.
Kumar has also headed up the Market Research function at Solvay Pharmaceuticals, Inc., which has since been merged with Abbott
Laboratories, where he was responsible for Market Research and Competitive Intelligence. He has a Master’s degree in Engineering and an
MBA from Emory University.
_______________________________________________________________________________________________________________
|
|
|
|
Harris Kaplan
CEO
Healogix
Harris has led Healogix from its start in 2004, overseeing its emergence as one of the premier market research and consultancies serving the
pharmaceutical industry. He brings a wealth of experience having been involved in the development and launch of over 75 new Rx products
including blockbusters Crestor, Rituxan, Nexium, Lipitor, Norvasc, Viagra and Herceptin. His unique perspective, distinctive personality and
enviable track record enables Harris to quickly gain the respect and trust of executives at leading pharmaceutical companies around the world.
Harris co-founded Migliara-Kaplan Associates which grew steadily under his leadership to become the world's largest custom marketing
research company, serving 19 of the top 20 pharmaceutical companies. Migliara-Kaplan Associates specialized in helping companies identify
new product opportunities. Migliara-Kaplan was acquired by NFO in 1996 and is now part of TNS Healthcare.
Harris was also cofounder of Cozint Interactive which was acquired by GFK, the German based research company. Harris serves as an
advisor to several venture capital funds and is on the Board of Directors of Informed Medical Communications, Informedix, and the Kernan
Orthopedic Hospital.
_______________________________________________________________________________________________________________
|
| |
|
Jeff Kenin
Director, Global Consumer Insights and Care
Merck Consumer Care
_______________________________________________________________________________________________________________
|
| |
|
James Kirk
Practice Leader
Quintiles
_______________________________________________________________________________________________________________
|
|
|
|
Jeff Kozloff
President
Verilogue
Jeff Kozloff is a co-founder of Verilogue and serves as president and CEO. Jeff has spent over 10 years in the pharmaceutical industry,
specializing in market research, strategic consulting and new product development for large pharmaceutical companies and marketing service
firms. Prior to launching Verilogue in 2006, Jeff served as a long-term consultant for Bristol-Myers Squibb, working on a variety of domestic and
international research projects. Previously, Jeff held various management roles at TargetRx, Inc., including positions in marketing, new product
development and sales.
Recently, Jeff was named to the 2010 PharmaVoice 100, being recognized by peers as one of the most inspiring people in the pharmaceutical
industry. He is Currently the Treasurer of PMRG and a member of CASRO and SPBT. Jeff holds a degree from the Wharton School at the
University of Pennsylvania and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies (US
patent # 20040210471).
_______________________________________________________________________________________________________________
|
|
|
|
Jackie Kwan
Director, Business Development
Medefield Hong Kong
Jackie is responsible for advising and servicing clients looking to field physician fieldwork studies across Asia. Jackie brings with her a wealth
of experience in both on and offline fieldwork, and has worked over her 14 year career both on the fieldwork supplier and agency side with the
likes of GfK and Synovate. Jackie is currently based in Medefield's Hong Kong office.
_______________________________________________________________________________________________________________
|
|
|
|
Linda Mauro
Principal
illume,llc
Linda has 20+ years of applied market research experience with national and global companies of all sizes. Leading research in consumer
and pharmaceutical industries has played a prominent role in her consulting portfolio. She has worked on a vast array of research initiatives
across many therapeutic areas. Additionally, she has extensive experience with OTC, Rx, and Rx-to-OTC switches and with different segments
including consumers, patients, and HCPs. Linda is known for expertly adapting innovative research tools developed for the CPG industry to
benefit the pharmaceutical industry. New product launches, insight mining, target identification, advertising development, optimization and
measurement are some of her proficiencies. Further, Linda is helping clients incorporate the use of digital and social media in research.
Linda is a Principal of illume – a strategic market research consulting firm that specializes in supporting corporate market research efforts and
customized training.
Linda graduated Magna Cum Laude from the University of Vermont with a BS in Business Administration. She also holds an MA in Sociology
specializing in Social Science Research Methods from the University of Pittsburgh, and was a PhD candidate. In November 2010, Linda was a
finalist for the 2010 Disruptive Innovator Award for her contribution to an award-winning DTC campaign. Linda has taught and presented
market research seminars at the university level. She worked for Carnegie Mellon’s Department of Psychology and the University Center for
Social and Urban Research at the University of Pittsburgh.
_______________________________________________________________________________________________________________
|
| |
|
Art McKee
Vice President of Client Services
Affinnova Life Sciences
Art is a member of the Life Sciences team at Affinnova where he serves as Vice President of Client Services. Affinnova's Life Sciences division
employs its patented Evolutionary Algorithms technology to improve clients' marketing outcomes by delivering optimized concepts capable of
generating high return on marketing investment rapidly and economically.
Art has over 18 years of experience working effectively with senior marketing and sales teams on key business challenges and strategic
product development initiatives. He has held senior positions on both the pharmaceutical manufacturer and marketing research services side
of the business and has extensive experience across all types of marketing research to help pharmaceutical clients build their brands. Art has
held senior leadership positions at some of the leading global market research agencies including TNS and Ziment where he helped clients
improve their competitive position through the use of scientifically sound and strategic research methodologies. On the manufacturer side of
the business, Art served as Senior Manager of Market Research at Wyeth-Lederle Vaccines, where he was on two launch products, including
Prevnar.
_______________________________________________________________________________________________________________
|
| |
|
Anindita Niyogi
Director, Enbrel Market Analytics
Pfizer Inc.
_______________________________________________________________________________________________________________
|
|
|
|
Kirk Olson
Vice President, Social Spaces
Ipsos Open Thinking Exchange
Kirk Olson brings fresh perspectives to research challenges through an innovative mix of qualitative and quantitative methods, social media
expertise and consumer trend tracking. He currently directs analytics and reporting practices for iOTX social spaces. Prior to Ipsos, Kirk was
Director of Insights + Innovation at Passenger, a technology and research company focused on online communities. He directed community
strategy and insights for a wide range of clients including Procter & Gamble, adidas, American Express, Vh1 and many others. His work with
P&G spanned multiple divisions including beauty and grooming, health and well-being, snacking, fabric care and eCommerce. Before joining
Passenger, Kirk was a vice president at Iconoculture, where he spent 11 years and helped transform the company from a boutique custom
consultancy to an international leader in consumer trends research. While there, he delivered insights to clients across industries, including
food and beverage (General Mills, Frito Lay, Coca-Cola, Diageo), media (MTV, Paramount, Time Warner, Disney), retail (Sears, Target,
Wal-Mart), financial services (JP Morgan) and many more. Kirk holds a B.A. in English and French from Hamline University. He studied critical
theory at Université Paris III - Sorbonne Nouvelle in Paris, France. He is currently attending Columbia University where he is a candidate for a
master of science, strategic communications.
_______________________________________________________________________________________________________________
|
|
|
|
Tim O’Rourke
Chief Research Officer
Healogix
Tim has led Healogix research effort for the last three years. His background includes more than 20 years of experience in basic and applied
research and a Ph.D. in cognitive neuroscience from Tufts University. He is responsible for driving research methodology and analysis at
Healogix and developing leading-edge research and analytical tools for the company. For the last 10 years Tim’s focus has been on using the
tools of marketing science to estimate and simulate how health care professionals treat their patients. Currently Tim is expanding how we
make predictions about decision making to include both deliberate and decisive behaviors.
Tim has more than a decade of industry experience, delivering accessible and actionable information across every major pharmaceutical
category. He has presented repeatedly at industry conferences on advanced analytic topics including product adoption, market segmentation,
and message optimization.
Prior to Healogix, Tim led the life science practice at The Modellers, a leading market analysis consultancy working across a broad range of
industries including financial, automotive, and packaged goods. His background in the industry also includes stints at Ziment (now Kantar
Health) and Eidetics (now Quintiles) as a methodologist, where he was an integral part of significant periods of growth.
_______________________________________________________________________________________________________________
|
| |
|
Erik Overby
Vice President, Client Services
Affinnova Life Sciences
Erik is Vice President Client Services at Affinnova Life Sciences. He has a comprehensive understanding of pharmaceutical marketing from his
16 year track record of performance in roles of increasing responsibility in market development, managed care and marketing at
SmithKlineBeecham and GlaxoSmithKline.
In his last role at GSK, prior to joining Affinnova, Erik led a cross-functional US commercial team of more than 20 members responsible for the
data release and pre-launch of strategic and tactical plans for a future indication of a high profile GSK brand.
He and his family live in the Philadelphia Main Line area of PA.
_______________________________________________________________________________________________________________
|
|
|
|
Geeta Padbidri
Director of Market Research
NPS Pharmaceuticals
Geeta has over 17 years of experience in providing deep strategic insights and commercial direction for large, mid, and small-size
biopharmaceutical companies for marketed Global brands and valuation of new product and licensing opportunities. She has extensive
launch related experience in a wide range of therapeutic areas such as Rheumatoid arthritis, Oncology, Schizophrenia, HIV, Cardiology,
Endocrinology, and Gastroenterology, and with Orphan and rare disease drugs. Prior to joining NPS Pharmaceuticals, Geeta has worked at
Pfizer, Roche (Genentech), Otsuka America Pharmaceuticals, and DuPont-Merck Pharmaceuticals.
_______________________________________________________________________________________________________________
|
|
|
|
Sharon Paik
VP
Ipsos Health
Sharon has over 10 years of experience within health and pharmaceutical marketing research with a particular orientation towards global
research. Her work spans virtually all therapeutic areas, where she has designed and managed both qualitative and quantitative studies at
every phase of the product lifecycle including communication research, segmentation, buying process research, conjoint, pricing, new product
development, therapeutic market assessment, and managed care.
Sharon has a degree in biology and also an M.B.A. with an emphasis on healthcare management, marketing, and management information
systems. Her background is varied and unique with experiences in graduate biological and medical research, healthcare strategic planning,
multi-media communications, marketing, and marketing research.
She is heavily published, both on the market research and the clinical side and has presented innovative new approaches at global market
research conferences like PMRG, and at clinician conferences.
_______________________________________________________________________________________________________________
|
|
|
|
Julie Pilon
Director Healthcare
in-sync
As a Director, Julie helms some of our most challenging projects, leveraging her extensive experience in a broad range of therapeutic areas –
including RA, AS, PSA, Psoriasis, Crones Disease, Alzheimer’s, cardiovascular diseases, diabetes, oncology, and others - to pave innovative
new territories for client brands and high profile corporate initiatives.
Julie joined in-sync after 7-years within Bayer’s Sales and Marketing Divisions. As the Product Manager for Adalat XL, Julie was instrumental in
successfully repositioning the brand and identifying creative solutions to safety issues. Julie was also responsible for the strategic direction of
Cipro in developing positioning for the drug’s new market indications (Titus, intra-abdominal, sinusitis), working in collaboration with
International KOLs. Before leaving Bayer to join in-sync, Julie was heavily involved in developing and launching a national and global strategy
for Baycol .4 mg.
As her experience attests, Julie is passionate about meeting her clients’ challenges, business needs and going beyond expectations by truly
transforming their brands into product leaders within highly competitive markets. Julie is currently leading the launch the in-sync offices in NY
and will be permanently based in NYC as of August 2011.
_______________________________________________________________________________________________________________
|
| |
|
Mini Pinto
Global Customer Insights Director
Merck & Co., Inc.
_______________________________________________________________________________________________________________
|
|
|
|
Robert Ramirez
Vice President
Ipsos
Rob manages the integration of Ipsos’ qualitative/quantitative business in the health sector. Rob has over 17 years of health care industry
experience developing and managing market research strategies. Rob brings a unique view of the health care landscape having previous
worked for Oxford Health Plans (MCO), Merck Medco (PBM), and Pfizer, Inc. Prior to joining Ipsos Understanding Unlimited, Rob spent several
years managing Pharmaceutical qualitative and quantitative studies for a boutique consulting firm.
He brings strategic insights and creative problem solving to his clients’ business questions.
Rob has an MBA in Health Care Administration from Sacred Heart University, and a Bachelor of Arts degree in Marketing and Advertising from
Flagler College.
_______________________________________________________________________________________________________________
|
|
|
|
Kathleen Regele
Payer and Healthcare Provider Customer Insights
GlaxoSmithKline
Kathleen Regele has a broad-based career within the pharmaceutical industry, ranging from analytic chemist to pharmaceutical manufacturing
and QA, as well as Sales, New Product Planning, Forecasting and Market Research. Her industry experience includes leadership roles in
New Product Development, Opportunity Assessments, Market Research, and Commercial Analytics for CNS, anti-infectives, cardiovascular,
respiratory and men’s health products at Zeneca and GlaxoSmithKline. Current responsibilities include Research, Analytics and Insight
development for Healthcare Payer Marketing at GlaxoSmithKline.
Kathleen’s roles have included direct involvement with, and overseeing teams, developing effective methodologies, processes, and solutions
to evolve pharmaceutical market research approaches that address business needs and shape marketing strategy: Scenario Planning for
new Therapeutic Market Entrants, New Product Marketing Strategy Development, Direct-to-Consumer Advertising, ROI Models, Relationship
Marketing, Insight Development, and Payer Marketing and Customer Market Access.
_______________________________________________________________________________________________________________
|
| |
|
David Rosen
Director, Forecasting, Analytics & Market Research
Purdue Pharma L.P.
_______________________________________________________________________________________________________________
|
|
|
|
Paul Saatsoglou
Executive Director- Market Research & Business Analytics
Eisai, Inc.
Paul Saatsoglou is the Executive Director of Market Research & Business Analytics for Eisai Inc. and has been in this position since
September 2005. Paul is responsible for the areas of Market Research, Forecasting, Business Analytics and supports Brand Planning and
various strategic initiatives including Business Development evaluations. His function supports all marketed and near launch Eisai Brands.
His team is comprised of about 25 professionals and consultants.
Prior to joining Eisai, Paul held various managerial positions in pharma companies, Pfizer, Janssen, Bristol-Myers Squibb & IMS Health. Paul
is a Fulbright Scholar, holds a BA in Physics and graduated Magna Cum Laude from Franklin & Marshall College, Lancaster, PA. He also
holds an MSc and ABD from the Wharton School, Univ. of PA. He is a member of PMSA, PBIRG, PMRG and AMA. In his spare time, he enjoys
playing tennis, nature and the arts and is an avid sports car racing fan. His wife is a teacher of Romance languages at a private academy in
Princeton, NJ, and their daughter is a graduate of the New York University.
_______________________________________________________________________________________________________________
|
| |
|
Grace Samoil-Reynolds
Sr Director Global Strategic Analytics
Johnson & Johnson
Grace joined Johnson & Johnson in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through
roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology
and Pain at Ortho McNeil. Most recently, she is responsible for Market Research and Forecasting for the CNS and Pain Franchises in early
Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at
Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her
passion is driving innovation and future thinking.
_______________________________________________________________________________________________________________
|
| |
|
Gail Santoro
Global Business Analysis
GE Healthcare Systems
_______________________________________________________________________________________________________________
|
|
|
|
John Scaife
Director/Team Leader, Market Analytics
Pfizer Inc.
John Scaife leads a market analytics team within the Specialty Care Business Unit at Pfizer. Since joining the company in 2002, John has held
a series of positions of increasing responsibility providing strategic market analytic guidance across a number of therapeutic areas, including
pain, inflammation, and ophthalmology. The focus of John's work at Pfizer has been the commercial development of pipeline products and
evaluation of business development opportunities. John has a BA from the University of Chicago and an MS from the MIT Sloan School of
Management. Prior to joining Pfizer, John worked for Mercer Management Consulting in Boston and served in the United States Marine Corps.
_______________________________________________________________________________________________________________
|
|
|
|
Chris Schneider
Client Strategist
Roger Green and Associates, Inc.
Chris is currently a Client Strategist at Roger Green and Associates, Inc. His background includes time spent at Roche Pharmaceuticals,
where he last served as Director of Global Business Development for Roche Partnering. In this position, he directed business assessments
of pre-clinical and clinical in-licensing, M&A, and other business development opportunities across a number of therapeutic areas, including
oncology and immunology. Prior to his Business Development role, Chris performed economic analyses in the Roche US affiliate and was
responsible for developing the pricing and renal customer segment contracting strategy for a new product launch in the erythropoietin market.
As an entry into the pharmaceutical industry, Chris spent four years at Pfizer managing the financials for the Depression and Anxiety Portfolio.
Chris also served in the U.S. Navy as an Aircraft Mission Commander as well as a Defense Foreign Liaison Officer in the Pentagon. He is a
graduate of the United States Naval Academy and the University of Chicago, Graduate School of Business.
_______________________________________________________________________________________________________________
|
|
|
|
Susan Schwartz McDonald, PhD
President and CEO
National Analysts Worldwide
Dr. McDonald is the President and Chief Executive Officer of National Analysts Worldwide and leader of the firm's Healthcare practice. She
consults to clients on strategic marketing issues including demand forecasting and optimization, pricing, positioning, portfolio strategy, and
brand equity assessment. Dr. McDonald is a specialist in both segmentation and the application of forecasting techniques to healthcare
markets, having supported the launch of many pharmaceutical products and medical technologies in a wide range of therapeutic areas. Other
categories in which she has extensive experience include OTC pharmaceuticals, consumer packaged goods, and mass media. Dr. McDonald
also directs the Litigation Support practice of National Analysts Worldwide and has testified frequently in federal court proceedings on behalf of
pharmaceutical companies in the context of federal trademark challenges and unfair advertising claims. Most of her 35-year marketing career
was spent at Booz•Allen Hamilton (now Booz & Company), a worldwide management and technology consulting firm, of which she was a Vice
President for over five years. Her early professional years were spent as a journalist and a poet, contributing regularly to a number of major
magazines and newspapers, including National Review and Harper's. Dr. McDonald is also coauthor of a standard text on qualitative
research methods, The Group Depth Interview: Principles and Practice (Simon & Schuster/Prentice Hall). She lectures and writes frequently
on marketing issues and market research techniques, and has contributed to medical journals as well as marketing texts. Dr. McDonald is
the Chairman of the CASRO Board of Directors (Council of American Survey Organizations) and also plays a leadership role in the organization’
s Guidelines and Practices Committee (Co-chair), Marketing and Communications Committee (Co-chair), and Pharmaceutical Marketing
Research Taskforce (Chair). In addition, she serves on the Board of Directors of The Wistar Institute, a non-profit biomedical research institute
dedicated to discoveries in immunology, cancer, cardio-vascular diseases and aging. Dr. McDonald holds M.A. and Ph.D. degrees from the
University of Pennsylvania's Annenberg School, where she was trained in communications theory and social psychology. Her B.A. was
awarded magna cum laude, Phi Beta Kappa, from Smith College in 1969.
_______________________________________________________________________________________________________________
|
|
|
|
David Scowcroft
Senior Vice President
Ipsos Health
David brings 18 years experience in quantitative market research with the last 10 of those specializing in the healthcare sector. He has both
client side as well as full-service agency experience. David has deep experience designing and interpreting complex and analytically advanced
research. Prior to Ipsos, David built and led the quantitative research practice of in-sync, specializing in strategically significant research
studies in the US healthcare market.
David has deep agency research experience having worked at Lieberman Research Worldwide, Research International and the Angus Reid
Group. He also worked at Sanofi as a quantitative research methodologist on the launch of a significant molecule. Over the years, David has
worked in the research trenches, worked in Marketing Sciences, managed accounts and run quantitative research divisions. David graduated
with an honors M.A. in economics from Queen’s University in Kingston Canada in which he specialized in econometrics, game theory and
industrial organization.
._______________________________________________________________________________________________________________
|
| |
|
Rajul Shah
Director, Global Strategic Insights
Johnson & Johnson
Rajul has spent the past 19 years in strategic healthcare analytics and has an MBA in Pharmaceutical Marketing. She has been with Johnson
& Johnson for 14 years across US and Global Pharmaceutical businesses; just recently moving to the Medical Diagnostics & Device sector
where she is currently Director, Global Strategic Insights for Ethicon, Inc. Rajul especially enjoys brainstorming with her teams in the
development of actionable insights. During her time in global analytics, she has developed insights across several emerging market projects
that have contributed to the organization’s deeper understanding of Oncology Therapeutics in these markets.
_______________________________________________________________________________________________________________
|
|
|
|
Lisa Shaw
VP, Global Commercial Support
Merck & Co., Inc.
Lisa Shaw is a seasoned executive with more than two decades of experience in the commercial areas of the pharmaceutical business. She
firmly believes that the key to business success is the seamless integration between a sound brand strategy and the flawless execution
provided by a commercial support organization. Lisa is passionate about marketing excellence—transforming marketing capabilities to
effectively compete in the ever-changing commercial environment.
Lisa's 22-year career at Merck has spanned several product marketing teams and two continents. In her current role, she is the vice-president
responsible for leading the Global Commercial Support organization, which is dedicated to realizing the company's commercial strategic
plans. Her organization provides marketing support to help Merck achieve its objectives in the most effective and efficient manner, while also
creating value. The functions within Global Commercial Support include market research, learning and development, marketing
communications, and marketing operations.
Prior to her current role in Global Commercial Support, Lisa had a successful trajectory in the marketing organization. She led a global brand
team for Merck's respiratory products, where she defined global brand strategy and was responsible for effective lifecycle management and
portfolio management. Lisa has accumulated a wealth of experience in several therapeutic areas, in Merck's vaccines and pharmaceuticals
divisions, as well as in a corporate staff role.
Lisa was recognized as Merck's "Rising Star" for the 2010 HealthCare Business Woman's Association. Prior to joining Merck in 1989, Lisa
was a research assistant at an immunology biotechnology company in Sydney, Australia. She holds a Biomedical Science Degree from the
University of Technology in Sydney, Australia.
_______________________________________________________________________________________________________________
|
|
|
|
Peter Simpson
Principal
Segmedica
Thirty five years of business experience have taken Peter all over the globe. He has lived and worked in the US, UK and Belgium. He has
operated in most of the world's major markets, including Japan and all of Europe. Most of his career has been spent in the Specialty Chemical,
Pharmaceutical, Medical Device and Biotechnology areas. His experiences have included the General Management of major businesses, CFO
of several companies, Strategic Planning Executive for businesses up to $2.5BN of revenue, as well as acquisitions and divestments, all
within the precursor units of AstraZeneca. He is a member of the Royal Institute of Chartered Management Accountants.
He has been Director of Marketing at Life Technologies Inc., a global supplier to the Biotechnology and Biopharmaceutical industry and Vice
President of Consulting and Market Research at Lowe Healthcare, one of the world's largest medical advertising agencies.
His client experience includes AstraZeneca, Schering Plough, Johnson and Johnson, TAP Pharmaceuticals, Boston Scientific, C R Bard,
Pfizer, Merck and many more leading companies. He has also worked with HMO's, Hospitals and Physicians' Practices.
Peter’s skills include strategic planning processes, branding issues, healthcare marketing and innovative market research. In over a decade
of consulting with the healthcare industry he has conducted numerous research projects of all types and is an experienced interviewer and
facilitator. He has been researching and developing psychology based methodologies for medical market research for seven years and has
developed a number of novel techniques and processes.
_______________________________________________________________________________________________________________
|
| |
|
Jaya Subramaniam
Executive Director, MR Oncology
Bristol-Myers Squibb
__________________________________________________________________________________________________________________________________
|
|
|
|
R. Sukumar
President
Optimal Strategix Group
Dr. Sukumar is President and Founder of Optimal Strategix Group, Inc. He started the firm in 2002 after spending over 25 years in academia
and in corporate America. Sukumar taught Marketing Strategy in MBA and Executive MBA programs in top U.S. academic institutions including
Rutgers Business School,Thunderbird, Garvin School of International Management, the Smith School of Business at the Univ. of Maryland,
Bauer College of Business, Univ. of Houston; Jones School of Management, Rice University, and Univ. of Georgia. He was Associate Dean at
the Indian School of Business.
During the span of his academic career, Dr. Sukumar offered strategic marketing consulting services to companies in the consumer packaged
goods, financial services, hospitality and pharmaceutical industries. His recent clients include many Global 2000 companies. He has also
conducted executive education and war games projects for Fortune 500 companies.
Dr. Sukumar has also served as Vice President of Marketing Sciences for market research firms such asThe NPD Group, IPSOS‐Vantis
FMCand IPSOS‐Insight. He was co‐founder of Upsurgia, a software solutions provider for an integrated buyer‐seller relationship, and
Healogix, a consulting and market research company for the pharmaceutical industry, focused on the early development of new drugs and
medical devices.
Dr. Sukumar completed his MBA and Ph.D. from the University of Pittsburgh in Marketing and Business Administration. His undergraduate
degree is in Mechanical Engineering from the esteemed Indian Institute of Technology in India.
_______________________________________________________________________________________________________________
|
|
|
|
Karen Tibbals
Former Director, Team Leader, Global Market Research
Merck & Co., Inc.
Karen is a pharmaceutical market research professional, specializing in market research to launch new products. Her accomplishments
include the US launches of Diovan and Lotrel for Novartis and the global launch of Saphris/Sycrest for Schering-Plough. In addition, she was
responsible for expanding the pharmaceutical practice for Ipsos, resulting in a publication on parental segmentation with her client, the Merck
Vaccine group. She was co-chair of the PMRG Promotion Research Seminar for 10 years and has been a speaker at various conferences.
She is now Team Lead for Neuroscience at Merck.
_________________________________________________________________________________________________________________________________
|
|
|
|
Jocelyn Trokenheim
Sr. Director, Business Development
Takeda Pharmaceuticals
Jocelyn Trokenheim is Sr. Director, Business Development, at Takeda Pharmaceuticals North America, Inc. In this role, Ms. Trokenheim is
responsible for assessments and valuations of licensing, and merger and acquisition opportunities. Her efforts had contributed to Takeda’s
recent acquisition of Nycomed, the largest acquisition ever completed by Takeda and the second largest acquisition ever completed by a
Japanese company.
Prior to assuming the Business Development role, Ms. Trokenheim was Sr. Director, Business Insights and Strategy, at Takeda
Pharmaceuticals North America, Inc. Ms. Trokenheim built and led a department of 28 professionals, with responsibilities spanning across all
aspects of commercial analytics including forecasting, marketing analytics, decision science, market research, commercial reporting and data
governance, for all of Takeda’s in-market products, pipeline compounds, as well as business development opportunities. In addition to her
expertise in analytics, Ms. Trokenheim is an accomplished leader in developing in-house analytical capabilities and building skilled teams to
increase cross-functional collaborations and organizational efficiency.
Ms. Trokenheim started her career with ZS Associates, as one of the founding members of its market research practice while gaining
extensive experience in pharmaceutical sales and marketing analytics. Ms. Trokenheim has a B.S. and an MSBA degree in Business Analysis
from San Francisco State University, and received an MSc degree in Management Science from Queen’s University in Kingston, Ontario,
Canada.
__________________________________________________________________________________________________________________________________
|
|
|
|
Paul Villa
SVP
Ipsos Health
Paul’s background spans a decade and a half in the healthcare area where he has developed sound knowledge, experience and an
understanding of the US and global payer markets and numerous therapeutic areas, including but not limited to gastrointestinal,
cardiovascular (dyslipidemia, anticoagulation, hypertension, ischemia), metabolic (T1 and T2 diabetes), pain (OA, migraine, opioids,
anesthesia), and central nervous system.
He joined Synovate Healthcare from a small global research-based consultancy where he was responsible for leading global and pricing and
reimbursement projects.
Paul also has spent over a decade in the pharmaceutical industry where he has held positions of increasing responsibility covering many
aspects in the commercialization of products in managed markets (all channels) and pricing and contracting for launch, re-launch, megabrand
and niche products. Paul has also worked in the consulting industry as a marketing consultant as well as a lead engagement manager
focused on strategic cost reduction.
Paul earned a MBA in Marketing and Organizational Behavior from Cornell University and a BA in Psychology from Pomona College.
__________________________________________________________________________________________________________________________________
|
| |
|
Frank Wang
Director, Afinitor Global Business Analysis
Novartis Oncology
__________________________________________________________________________________________________________________________________
|
| |
|
Richard Withers
CEO
Deallus Group
Richard is the CEO of the Dealllus Group. Following several years service as a military intelligence officer, Richard retired, went to Business
School and started consulting to the Pharmaceutical Industry on intelligence matters.
Over his career he has facilitated over 100 strategic workshops such as War Games and Scenario Analysis events and has advised CI
Managers and their Customers in R&D across to Marketing on what to expect from CI and how to derive maximum value from it.
__________________________________________________________________________________________________________________________________
|
| |
|
Tjun Wong
Senior Director, Global Marketing Research
Shire Pharmaceuticals
__________________________________________________________________________________________________________________________________
|
| |
|
Dr. David J. Zweiback
Solo-Practitioner
Jenkintown, PA
David Zweiback has been practicing internal medicine since 1995 and has a case load of more than 600 patients per month. He has
appointments at three hospitals, where in addition to his casework, he manages both students and interns.
__________________________________________________________________________________________________________________________________
|
|
